Factors Influencing Clinical Decisions to Initiate Thyroxine Therapy for Patients With Mildly Increased Serum Thyrotropin (5.1-10.0 mIU/L)

Fatourechi, Vahab; Lankarani, Mahnaz; Schryver, Patricia G.; Vanness, David J.; Long, Kirsten Hall; Klee, George G.
May 2003
Mayo Clinic Proceedings;May2003, Vol. 78 Issue 5, p554
Academic Journal
Determines factors that influence clinicians' decisions to treat subclinical hypothyroidism. Most common abnormality of thyrotropin; Reasons for initiating thyroxine therapy for antibody-positive patients; Issue of physician reluctance to use thyroxine therapy for older patients.


Related Articles

  • Growth, development, and reassurement of hypothyroid infants diagnosed by screening. Hulse, J.A.; Grant, D.B.; Jackson, Doreen; Clayton, Barbara E. // British Medical Journal (Clinical Research Edition);5/15/1982, Vol. 284 Issue 6327, p1435 

    Reassesses the hypothyroid infants after the thyroid stimulating hormone screening. Analysis of the mental development scores; Association between thyroid stimulating hormone concentrations and concentrations of serum thyroxine (T4); Importance of regular monitoring for the serum T4...

  • Health Status, Psychological Symptoms, Mood, and Cognition in L-Thyroxine-Treated Hypothyroid Subjects. Mary H. Samuels; Kathryn G. Schuff; Nichole E. Carlson; Phyllis Carello; Jeri S. Janowsky // Thyroid;Mar2007, Vol. 17 Issue 3, p249 

    Objective: Many hypothyroid subjects receiving L-thyroxine (L-T4) complain of psychological symptoms or cognitive dysfunction. However, there is limited validated information on these self-reports. Design: Cross-sectional comparison of 20 euthyroid and 34 treated hypothyroid subjects, aged...

  • Neonatal screening for congenital hypothyroidism by measurement of plasma thyroxine and thyroid stimulating hormone concentrations. Griffiths, K.D.; Virdi, Narinder K.; Rayner, P.H.W.; Green, Anne // British Medical Journal (Clinical Research Edition);7/13/1985, Vol. 291 Issue 6488, p117 

    Assesses plasma thyroxine and thyroid stimulating hormone measurement for congenital hypothyroidism screening in Birmingham, England. Detection of an abnormality in thyroxine binding globulin production; Incidence of congenital hypothyroidism in Asian population; Disadvantages of the test.

  • Subclinical hypothyroidism in childhood. MJ O'Grady // Archives of Disease in Childhood;Mar2011, Vol. 96 Issue 3, p280 

    Subclinical hypothyroidism (SH) is defined as an elevated thyroid stimulating hormone (TSH) in association with a normal total or free thyroxine (T4) or triiodothyronine (T3). It is frequently encountered in both neonatology and general paediatric practice; however, its clinical significance is...

  • Primary hypothyroidism presenting as amenorrhoea and galactorrhoea with hyperprolactinaemia and pituitary enlargement. Heyburn, P.J.; Gibby, O.M.; Hourihan, M.; Hall, R.; Scanlon, M.F. // British Medical Journal (Clinical Research Edition);6/21/1986, Vol. 292 Issue 6536, p1660 

    Investigates the primary hypothyroidism in patients with the amenorrhea and galactorrhea syndrome. Cause of hyperprolactinemia; Association of adenomas secreting thyroid stimulating hormone with primary thyroid failure; Use of thyroxine in the resolution of symptoms.

  • Soy formula complicates management of congenital hypothyroidism. Conrad S C; Chiu H; Silverman B L // Archives of Disease in Childhood;Jan2004, Vol. 89 Issue 1, p37 

    AIMS: To test the hypothesis that feeding soy formula to infants with congenital hypothyroidism (CH) leads to prolonged increase of thyroid stimulating hormone (TSH). METHODS: The study was a review of 78 patients seen during their first year of life between 1990 and 1998. Data regarding...

  • Outcome of lower L-thyroxine dose for treatment of congenital hypothyroidism. Campos, Susana P.; Sandberg, David E. // Clinical Pediatrics;Oct1995, Vol. 34 Issue 10, p514 

    Evaluates the intellectual, behavioral, and growth outcomes of 23 congenitally hypothyroid newborns diagnosed by the New York State Neonatal Thyroid Screening Program and initially treated with 25 micrograms of L-thyroxine. Increased serum thyroxine (T4) values; Elevation of thyroid-stimulating...

  • Thyroid Replacement Debate Continues.  // Clinical Cardiology Alert;Apr2008, Vol. 27 Issue 4, p1 

    The article reports on the issue of whether thyroid replacement with levothyroxine (LT4) delivers adequate levels of triiodothyronine (T3) in hypothyroid patients through peripheral conversion. Several U.S. researchers found that such replacement to achieve thyrotropin (TSH) levels less than 4.5...

  • Thyrotropin-Secreting Adenoma in a Patient with Primary Hypothyroidism. Alyson Myers; Kimmo Hatanpaa; Christopher Madden; Ildiko Lingvay // Endocrine Practice;Nov2011, Vol. 17 Issue 6, pe135 

    Objective: To describe a patient who developed a thyrotropin (TSH)-secreting adenoma in the setting of primary hypothyroidism.Methods: We report the clinical, laboratory, and radiologic findings of a patient with a history of primary hypothyroidism who presented with headache, a bitemporal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics